These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6390143)
1. [Plasma levels of glucose and free insulin in diabetics after insulin administration using a traditional syringe and a jet injector]. Coscelli C; Palmari V; Saccardi F; Formica F Minerva Endocrinol; 1984; 9(2):309-12. PubMed ID: 6390143 [No Abstract] [Full Text] [Related]
2. Blood glucose and free insulin levels after the administration of insulin by conventional syringe or jet injector in insulin treated type 2 diabetics. Kerum G; Profozić V; Granić M; Skrabalo Z Horm Metab Res; 1987 Sep; 19(9):422-5. PubMed ID: 3319860 [TBL] [Abstract][Full Text] [Related]
3. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]
4. [Injections without needles in the treatment of insulin-dependent diabetes]. Robert JJ; Jos J Ann Pediatr (Paris); 1991 Apr; 38(4):225-8. PubMed ID: 2069356 [TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control. Lepore G; Corsi A; Dodesini AR; Nosari I; Trevisan R Diabetes Care; 2010 Jun; 33(6):e81. PubMed ID: 20508226 [No Abstract] [Full Text] [Related]
7. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes. Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103 [TBL] [Abstract][Full Text] [Related]
8. [Administration of semisynthetic human insulin by a spray injector]. Consoli A; Capani F; La Nava G; Nicolucci A; Prosperini GP; Santeusanio G; Sensi S Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1859-62. PubMed ID: 6394034 [TBL] [Abstract][Full Text] [Related]
9. Effect of insulin concentration on bioavailability during nasal spray administration. Valensi P; Zirinis P; Nicolas P; Perret G; Sandre-Banon D; Attali JR Pathol Biol (Paris); 1996 Apr; 44(4):235-40. PubMed ID: 8763584 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience with jet insulin injection in diabetes mellitus therapy: a clue to the pathogenesis of lipodystrophy. Cohn ML; Hingson RA; Narduzzi JV; Seddon JM Ala J Med Sci; 1974 Jul; 11(3):265-72. PubMed ID: 4451266 [No Abstract] [Full Text] [Related]
11. Comparison of insulin regimens and administration modalities in pregnancy complicated by diabetes. Schuster MW; Chauhan SP; McLaughlin BN; Perry KG; Morrison JC J Miss State Med Assoc; 1998 Jun; 39(6):208-12. PubMed ID: 9635386 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the absorption kinetics of subcutaneously administered insulin]. Misawa K Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384 [TBL] [Abstract][Full Text] [Related]
13. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery. Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974 [No Abstract] [Full Text] [Related]
14. Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection. Taylor R; Home PD; Alberti KG Diabetes Care; 1981; 4(3):377-9. PubMed ID: 7047114 [TBL] [Abstract][Full Text] [Related]
15. Twice-daily mixed regular and NPH insulin injections with new jet injector versus conventional syringes: pharmacokinetics of insulin absorption. Hallé JP; Lambert J; Lindmayer I; Menassa K; Coutu F; Moghrabi A; Legendre L; Legault C; Lalumière G Diabetes Care; 1986; 9(3):279-82. PubMed ID: 3525057 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785 [No Abstract] [Full Text] [Related]
17. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
18. [Cutaneous infection caused by Mycobacterium chelonae after self-injection of insulin using a jet injector]. Escobedo JA; Gil D; Pascual A; Aguirre JM Enferm Infecc Microbiol Clin; 1994 May; 12(5):274-5. PubMed ID: 8049299 [No Abstract] [Full Text] [Related]
19. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes]. Ledermann H; Höxter G Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886 [TBL] [Abstract][Full Text] [Related]
20. A survey of patient preference for insulin jet injectors versus needle and syringe. Denne JR; Andrews KL; Lees DV; Mook W Diabetes Educ; 1992; 18(3):223-7. PubMed ID: 1451623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]